Humana Files 8-K on Operations & Financial Condition
Ticker: HUM · Form: 8-K · Filed: Jan 25, 2024 · CIK: 49071
| Field | Detail |
|---|---|
| Company | Humana Inc (HUM) |
| Form Type | 8-K |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, regulation-fd, results-of-operations
TL;DR
**Humana just dropped an 8-K on financial results, get ready for potential stock movement.**
AI Summary
Humana Inc. filed an 8-K on January 25, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD disclosure. This filing indicates that Humana is providing updated financial information to the public, which is crucial for investors to understand the company's current performance and future outlook. For shareholders, this means new data is available that could influence the stock's valuation and their investment decisions.
Why It Matters
This filing provides investors with the latest financial health update from Humana Inc., which can directly impact stock price and future investment sentiment.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently signal high risk, though the content of the disclosed financial results could be positive or negative.
Analyst Insight
Investors should review the full content of the financial results and Regulation FD disclosure once available to understand the specific impacts on Humana's performance and future outlook.
Key Players & Entities
- Humana Inc. (company) — the registrant filing the 8-K
- January 25, 2024 (date) — date of earliest event reported and filing date
- 500 West Main Street, Louisville, KY 40202 (address) — principal executive offices of Humana Inc.
- 1-5975 (number) — Commission File Number for Humana Inc.
- 61-0647538 (number) — IRS Employer Identification No. for Humana Inc.
FAQ
What is the primary purpose of Humana Inc.'s 8-K filing on January 25, 2024?
The primary purpose of Humana Inc.'s 8-K filing on January 25, 2024, is to report on its results of operations and financial condition, and to make a Regulation FD Disclosure, as indicated by the 'ITEM INFORMATION' sections.
What is Humana Inc.'s trading symbol and on which exchange is its Common Stock registered?
Humana Inc.'s Common Stock trades under the symbol 'HUM' and is registered on the New York Stock Exchange, as stated in the 'Securities registered pursuant to Section 12(b) of the Act' section.
What is the business address and phone number of Humana Inc. as listed in the filing?
The business address of Humana Inc. is 500 West Main Street, Louisville, KY 40202, and its telephone number is 502-580-1000, according to the filing's cover page.
Is Humana Inc. considered an emerging growth company according to this 8-K filing?
The filing includes a checkbox 'Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405', but it is not checked, implying Humana Inc. is not an emerging growth company.
What is the state of incorporation for Humana Inc.?
Humana Inc. is incorporated in Delaware, as specified on the cover page of the 8-K filing.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-01-25 06:35:33
Filing Documents
- hum-20240125.htm (8-K) — 31KB
- hum-2023q48kxex99x1brief.htm (EX-99.1) — 270KB
- hum-2023q48kxex99x2detailed.htm (EX-99.2) — 1169KB
- a4q2023humanaincpreparedre.htm (EX-99.3) — 69KB
- humanalogoa05.jpg (GRAPHIC) — 11KB
- humanalogoa051.jpg (GRAPHIC) — 11KB
- image_0.jpg (GRAPHIC) — 41KB
- 0000049071-24-000007.txt ( ) — 1865KB
- hum-20240125.xsd (EX-101.SCH) — 2KB
- hum-20240125_lab.xml (EX-101.LAB) — 24KB
- hum-20240125_pre.xml (EX-101.PRE) — 12KB
- hum-20240125_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended December 31, 2023, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company's website at www.humana.com . A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. Additionally, a copy of management's prepared remarks on the company's 2023 financial results and expectations for future earnings, is attached hereto as Exhibit 99.3 and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release 99.2 Earnings Release and Statistical Pages 99.3 Prepared Management Remarks 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: January 25, 2024